type
interferon
system
play
critic
role
limit
spread
viral
infect
virus
induc
product
interferon
ifn
bind
receptor
ifnar
trigger
jakstat
signal
cascad
result
induct
interferonstimul
gene
isg
isg
function
inhibit
viral
replic
regul
host
immun
respons
among
isg
ubiquitinlik
molecul
one
strongli
induc
protein
similar
ubiquitin
ifn
induc
conjug
cascad
coval
link
varieti
cellular
protein
suggest
regul
differ
cellular
process
studi
perform
past
sever
year
shown
play
central
role
host
antivir
respons
mani
virus
mice
lack
display
increas
suscept
multipl
virus
furthermor
sever
virus
develop
immun
evas
strategi
directli
target
pathway
work
underway
determin
mechan
function
antivir
molecul
therapi
target
pathway
develop
futur
keyword
interferon
antivir
ubiquitinlik
molecul
introductionth
pathway
first
note
type
ifn
treat
cell
lysat
soon
identifi
sequenc
homolog
ubiquitin
review
refer
crystal
structur
reveal
compos
two
domain
assum
fold
open
access
virus
similar
ubiquitin
structur
one
abundantlyinduc
transcript
upon
type
ifn
treatment
well
follow
tlr
ligat
viral
infect
synthes
kda
precursor
protein
proteolyt
process
matur
kda
form
follow
stimul
type
ifn
exist
three
distinct
statesfre
within
cell
releas
extracellular
space
conjug
target
protein
earli
identif
report
found
extracellular
form
stimul
human
monocyt
type
ifn
result
much
accumul
releas
media
furthermor
repeat
treatment
patient
ser
result
detect
level
sera
within
hour
treatment
nt
contain
signal
sequenc
therefor
mechan
releas
remain
unknown
sever
immunomodulatori
activ
attribut
recombin
extracellular
includ
abil
induc
nk
cell
prolifer
augment
lymphokineactivatedkil
lak
activ
stimul
product
induc
dc
matur
function
chemotact
factor
neutrophil
date
cell
surfac
receptor
identifi
bind
therefor
role
potenti
cytokin
activ
play
vivo
yet
ascertain
similar
ubiquitin
matur
form
contain
ctermin
lrlrgg
motif
mediat
coval
conjug
target
protein
term
isgyl
within
two
hour
type
ifn
treatment
free
detect
cell
lysat
follow
conjug
format
hour
later
isgyl
util
mechan
similar
ubiquitin
requir
three
enzymat
step
figur
activ
enzym
initi
identifi
robert
krug
colleagu
function
pathway
form
atpdepend
thioester
bond
recent
gener
knockout
mous
confirm
role
mice
express
free
form
conjug
follow
lp
stimul
viral
infect
follow
activ
transfer
activesit
cystein
conjug
enzym
follow
transfer
lysin
residu
target
protein
ligas
date
three
ligas
shown
interact
pathway
includ
human
mous
hhari
isgyl
revers
due
specif
remov
conjug
protein
deconjug
enzym
screen
addit
deubiquitin
enzym
could
target
conjug
identifi
potenti
candid
whose
signific
remain
determin
vivo
mani
way
pathway
parallel
ubiquitin
conjug
pathway
differ
exist
first
member
conjug
cascad
upregul
type
ifn
second
unlik
ubiquitin
hundr
respons
individu
substrat
specif
pathway
appear
domin
ligas
coordin
conjug
major
substrat
inhibit
express
sirna
abrog
greater
conjug
format
induc
recent
studi
durfe
colleagu
shown
associ
polyribosom
appear
target
newli
synthes
protein
includ
viral
protein
modif
help
explain
broad
substrat
specif
conjug
cascad
follow
exposur
ifn
cell
upregul
free
intracellular
conjug
target
protein
releas
extracellular
space
shown
red
immun
evas
strategi
util
virus
circumv
pathway
numer
screen
identifi
nearli
candid
target
span
divers
array
biolog
process
includ
protein
translat
cell
cycl
regul
signal
transduct
glycolysi
cell
motil
immun
regul
target
suggest
may
involv
regul
varieti
host
process
recent
review
elsewher
howev
still
larg
unknown
impact
modif
target
protein
unlik
ubiquitin
isgyl
appear
directli
target
protein
proteasomemedi
degrad
chain
appear
form
interact
compon
proteasom
identifi
base
upon
analysi
limit
number
target
protein
appear
function
either
disrupt
activ
target
protein
andor
alter
local
within
cell
mechan
occur
larg
unknown
remain
import
focu
futur
investig
interestingli
mani
potenti
target
protein
identifi
includ
protein
play
import
role
immun
host
antivir
respons
pkr
mxa
recent
observ
mediat
isgyl
activ
translat
protein
would
make
mani
ifn
induc
protein
import
target
would
also
provid
addit
support
play
signific
role
viral
infect
discuss
import
host
respons
viral
infect
confirm
studi
evalu
impact
overexpressionknockdown
viral
growth
vitro
studi
mice
defici
member
conjug
cascad
evalu
viral
immun
evas
strategi
target
impact
pathway
investig
vitro
vivo
tabl
studi
look
either
overexpress
knockdown
use
sirna
implic
regul
influenza
vaccinia
vesicular
stomat
viru
vsv
sendai
japanes
enceph
viru
jev
well
releas
viruslik
particl
vlp
deriv
avian
sarcoma
leukosi
viru
aslv
also
recent
report
function
provir
molecul
augment
hepat
c
viru
hcv
replic
although
mechan
yet
determin
studi
util
sirna
target
also
shown
either
increas
viral
growth
vaccinia
sendai
ndv
abil
partial
rescu
type
ifn
induc
inhibit
growth
influenza
ebola
vlp
case
effect
modest
chang
viral
growth
rang
fold
mechan
regul
viral
growth
unknown
major
pathogen
overexpress
studi
member
conjug
cascad
coexpress
suggest
conjug
target
protein
requir
antivir
effect
except
studi
ebola
viru
vlp
releas
overexpress
inhibit
vlp
bud
despit
observ
either
overexpress
knockdown
strategi
differ
viral
growth
influenza
herp
simplex
viru
sindbi
vsv
wild
type
vaccinia
viru
report
cell
deriv
either
furthermor
unknown
vitro
effect
translat
differ
vivo
exampl
defect
vsv
bud
note
overexpress
studi
date
phenotyp
observ
report
mice
infect
vsv
lack
either
futur
studi
need
confirm
phenotyp
vivo
strongest
evid
function
antivir
molecul
come
analysi
mice
member
conjug
cascad
delet
first
genet
defici
mous
gener
pathway
deconjug
enzym
mice
die
around
week
age
hydrocephalu
character
mice
found
increas
level
conjug
increas
ifn
signal
transduct
note
prolong
phosphoryl
increas
product
isg
also
resist
viral
bacteri
infect
suggest
dysregul
conjug
lead
phenotyp
conclus
challeng
initi
character
reveal
defect
develop
intact
interferon
signal
normal
resist
vsv
lymphocyt
choriomening
viru
lcmv
infect
addit
phenotyp
observ
abrog
upon
gener
mice
lack
indic
phenotyp
independ
subsequ
studi
determin
addit
role
deconjug
enzym
also
function
neg
regul
type
ifn
receptor
signal
confirm
function
antivir
molecul
come
care
analysi
mice
mice
compar
wild
type
mice
suscept
infect
sindbi
viru
influenza
b
viru
murin
gammaherpesviru
free
conjug
detect
viral
infect
isgyl
shown
requir
resist
sindbi
influenza
viru
vivo
increas
lethal
seen
infect
sindbi
viru
could
rescu
doubl
subgenom
sindbi
viru
express
wild
type
rescu
virus
contain
mutat
termin
lrlrgg
motif
abrog
conjug
addit
mice
lack
enzym
still
express
free
fail
form
conjug
also
suscept
sindbi
viru
influenza
viru
infect
studi
vaccinia
viru
found
display
differ
lethal
minim
increas
viral
load
follow
infect
wild
type
viru
protein
identifi
antagonist
inhibit
conjug
infect
mutant
viru
lack
antagonist
result
increas
lethal
compar
wt
mice
provid
anoth
model
play
role
therefor
viral
system
antivir
action
mediat
conjug
target
protein
investig
need
determin
viral
host
protein
target
infect
understand
mechan
modif
impact
upon
viru
mechan
function
antivir
molecul
unknown
like
differ
virus
recent
studi
provid
insight
regul
host
antivir
respons
virus
seri
studi
look
virus
util
host
ubiquitin
machineri
viral
egress
implic
import
regul
pathway
retrovirus
filovirus
util
endosom
sort
complex
requir
transport
escrt
iiii
pathway
viral
egress
okumura
et
al
first
demonstr
overexpress
mimick
abil
type
ifn
block
releas
hiv
particl
cell
util
sirna
found
inhibit
due
activ
overexpress
inhibit
ubiquitin
hiv
gag
host
disrupt
interact
protein
known
critic
effici
viral
bud
author
fail
detect
isgyl
either
hiv
gag
directli
propos
loss
ubiquitin
may
lead
less
stabl
bud
complex
therefor
decreas
bud
observ
follow
two
independ
studi
demonstr
also
inhibit
ebola
viru
vlp
releas
bud
system
requir
interact
late
domain
member
host
escrt
pathway
ie
monoubiquitin
mediat
ligas
thought
requir
effici
releas
studi
okumura
et
al
malakhova
et
al
overexpress
independ
conjug
system
inhibit
ebola
viru
vlp
releas
mechanist
found
interact
abrog
transfer
ubiquitin
enzym
activ
site
prevent
ubiquitin
target
protein
includ
ebola
viru
extend
studi
vsv
rhabdoviru
contain
similar
ldomain
also
interact
ligas
effici
bud
two
studi
identifi
mechan
regul
viral
bud
first
time
implic
unconjug
antivir
molecul
addit
mechan
target
retrovir
releas
cell
late
bud
process
recent
identifi
releas
aslv
vlp
similar
inhibit
overexpress
express
inhibit
aslv
gag
ubiquitin
support
earlier
find
howev
author
abl
reconstitut
independ
bud
coval
link
either
aslv
gag
protein
escrtiii
protein
allow
aslv
gag
enter
respect
bud
pathway
late
step
bud
process
construct
still
inhibit
suggest
second
mechan
mediat
inhibit
viral
releas
ectop
express
block
associ
gag
aslv
gag
inhibit
interact
coactiv
prevent
format
oligomer
enzym
need
disassembl
escrt
complex
facilit
multipl
round
bud
escrtiii
protein
note
modifi
deplet
sirna
made
bud
aslv
vlp
resist
inhibit
togeth
studi
provid
first
insight
one
mechan
may
regul
viral
infect
target
multipl
stage
bud
virus
util
ubiquitin
machineri
escrt
pathway
case
studi
perform
use
overexpress
system
whether
interactionmodif
also
take
place
signific
viral
infect
cell
anim
model
remain
determin
host
protein
clearli
identifi
target
isgyl
although
discuss
impact
modif
still
larg
debat
persist
question
whether
viral
protein
also
target
modif
recent
two
group
demonstr
modif
influenza
viral
protein
function
ifn
antagonist
viral
infect
studi
zhao
et
al
author
determin
viral
infect
domin
lysin
modifi
posit
rnabind
domain
isgyl
site
disrupt
associ
protein
requir
nuclear
import
gener
recombin
viru
lysin
residu
mutat
result
greatli
reduc
isgyl
viral
infect
demonstr
isgyl
inhibit
replic
influenza
cell
second
studi
tang
et
al
author
identifi
seven
lysin
potenti
isgyl
site
found
critic
vivo
gener
mutant
virus
carri
k
r
mutat
either
lysin
residu
result
augment
viral
growth
cultur
cell
increas
virul
vivo
studi
provid
first
evid
viral
protein
also
target
isgyl
modif
impact
virul
futur
experi
need
determin
whether
influenza
viral
protein
modifi
influenza
viru
infect
final
recent
studi
durfe
et
al
found
ligas
associ
polyribosom
therefor
target
newli
synthes
protein
modif
author
propos
viral
protein
would
primari
target
isgyl
went
demonstr
l
protein
isgyl
transfect
experi
hpv
pseudoviru
system
util
determin
isgyl
impact
infect
author
found
pseudoviru
gener
cell
cotransfect
result
decreas
infect
viru
remain
seen
modif
l
protein
occur
viral
infect
taken
togeth
result
support
viral
protein
target
addit
work
need
determin
modif
account
entir
phenotyp
seen
mice
lack
host
protein
modif
also
contribut
antivir
action
mani
target
protein
identifi
proteom
screen
includ
protein
play
import
role
immun
pkr
mxa
modif
protein
may
contribut
antivir
activ
specif
virus
although
point
time
contribut
antivir
state
unclear
due
part
unknown
fate
vast
major
isgyl
target
protein
recent
mechan
alter
function
sever
substrat
identifi
appear
directli
impact
function
modifi
protein
indirectli
impact
function
disrupt
ubiquitin
exampl
neg
regul
scaffold
protein
filamin
b
unmodifi
filamin
b
facilit
type
ifninduc
apoptosi
recruit
isgyl
filamin
b
howev
releas
scaffold
prevent
jnk
activ
apoptosi
suggest
mechan
may
protect
uninfect
bystand
cell
ifnmedi
apoptosi
hypothesi
await
experiment
contrast
conjug
posit
regul
transcript
factor
promot
type
ifn
induct
isgyl
abolish
bind
protein
promot
ubiquitin
subsequ
degrad
inhibit
interact
correl
decreas
degrad
increas
induct
modif
sever
ubiquitin
shown
disrupt
abil
form
thioester
bond
ubiquitin
therefor
disrupt
ubiquitin
downstream
target
contribut
modifi
host
protein
antivir
activ
still
investig
host
pathway
play
signific
role
antivir
respons
often
target
virus
viral
immun
evas
strategi
identifi
target
pathway
figur
provid
support
import
pathway
host
antivir
respons
date
evas
strategi
target
conjug
either
inhibit
format
conjug
disrupt
conjug
form
first
identifi
immun
evas
strategi
target
pathway
describ
robert
krug
colleagu
studi
interact
partner
influenza
viral
protein
determin
infect
cell
high
moi
variou
influenza
b
viral
strain
upregul
free
conjug
detect
mechan
inhibit
mediat
gene
noncoval
bound
inhibit
abil
interact
subsequ
activ
therebi
inhibit
conjug
format
protein
influenza
b
virus
antagonist
ifn
retain
abil
bind
inhibit
conjug
format
despit
evas
strategi
highli
suscept
influenza
b
viru
infect
appear
due
larg
speci
specif
interact
bind
human
nonhuman
primat
murin
canin
may
provid
import
insight
restrict
host
rang
influenza
b
virus
compar
influenza
virus
addit
influenza
b
viru
vaccinia
viru
also
shown
encod
viral
protein
antagon
case
protein
known
antagon
host
ifn
respons
sever
mechan
inhibit
pkr
rnasel
block
activ
also
shown
bind
ctermin
domain
protein
appear
inhibit
conjug
format
although
precis
mechan
remain
determin
model
display
almost
differ
wt
mice
follow
infect
wild
type
vaccinia
viru
howev
delet
protein
viru
result
increas
virul
demonstr
role
host
respons
efficaci
immun
evas
strategi
mount
vaccinia
viru
contrast
first
two
exampl
remain
strategi
taken
advantag
proteas
activ
differ
virus
hydrolyz
ubiquitin
target
protein
first
strategi
identifi
employ
sever
virus
ovarian
tumor
domain
otu
contain
proteas
otu
domain
famili
recent
identifi
deubiquitin
dub
enzym
compris
group
cystein
proteas
particip
substratespecif
deubiquitin
l
protein
crimean
congo
hemorrhag
fever
viru
cchfv
dugb
viru
dugv
well
protein
arterivirus
equin
arter
viru
eav
porcin
respiratori
reproduct
syndrom
viru
prrsv
contain
otu
domain
unlik
mammalian
counterpart
cezann
deubiquitin
activ
specif
substrat
viral
protein
found
global
deconjug
ubiqitin
chain
via
cystein
proteas
activ
activ
conjug
express
viral
otu
domain
either
gener
transgen
mous
express
cchfv
l
protein
overexpress
protein
directli
recombin
sindbi
viru
abl
inhibit
antivir
activ
addit
viral
otu
proteas
abl
inhibit
depend
signal
final
addit
otu
domain
contain
proteas
recent
work
look
papainlik
proteas
sar
coronaviru
sarscov
plpro
human
coronaviru
protein
found
deubiquitin
deisgyl
target
protein
signific
activ
viral
infect
still
investig
case
viral
immun
evas
strategi
allow
virus
evad
ifn
signal
pathway
play
critic
role
host
respons
viral
infect
signific
progress
made
identifi
compon
conjug
cascad
understand
protein
induc
viral
infect
identifi
potenti
target
isgyl
may
regul
varieti
cellular
process
appear
play
critic
role
host
respons
viral
infect
support
studi
also
identif
viral
immun
evas
strategi
target
pathway
sever
viral
system
appear
regul
base
upon
vitro
vivo
studi
recent
effort
begun
dissect
mechan
regul
respons
howev
despit
progress
mani
question
still
remain
focu
futur
investig
first
mani
viral
system
observ
made
either
overexpress
studi
knockdown
studi
need
confirm
vivo
second
addit
mechanist
studi
necessari
understand
regul
divers
group
virus
inform
hand
abl
develop
therapeut
target
pathway
third
viral
protein
isgyl
least
influenza
viru
infect
remain
unclear
antivir
effect
due
sole
modif
viral
protein
modif
host
protein
also
contribut
antivir
effect
fourth
report
durfe
et
al
suggest
activ
translat
protein
target
isgyl
least
would
includ
mani
gene
induc
type
ifn
express
cell
viral
infect
impact
isgyl
protein
fate
remain
unansw
fifth
date
antivir
activ
identifi
viral
immun
evas
strategi
target
conjug
howev
studi
ebola
vlp
suggest
free
unconjug
may
mediat
antivir
effect
unanchor
ubiquitin
chain
recent
shown
modifi
nfkb
rigi
signal
pathway
therefor
evalu
potenti
activ
unconjug
within
cell
releas
cell
interest
final
ifn
pleotrop
effect
immun
respons
determin
whether
play
role
respons
could
import
consequ
develop
futur
therapeut
vaccin
strategi
